Quotient Limited to Participate in Two Upcoming Conferences
November 09 2020 - 4:05PM
Quotient Limited (NASDAQ: QTNT), a commercial-stage
diagnostics company (Quotient or the Company), headquartered in
Eysins, Switzerland, today announced that the Company will
participate in two upcoming virtual investor conferences.
Stifel Virtual Healthcare
Conference
The Company will be presenting on Tuesday, November 17, 2020 at
8:00am ET.
Jefferies Virtual
London Healthcare Conference
The Company will be presenting on Wednesday, November 18, 2020
at 9:40am ET (2:40pm GMT).
Both presentations will be webcast live, and will be available
on the investor relations page of the Company’s corporate website
at www.quotientbd.com. Webcast replays will be archived on the
website for approximately 90 days.
About Quotient Limited
Building on over 30 years of experience in transfusion
diagnostics, Quotient is a commercial-stage diagnostics company
committed to delivering solutions that reshape the way diagnostics
is practiced. MosaiQ, Quotient’s proprietary multiplex microarray
technology, offers the world’s first fully automated, consolidated
testing platform, allowing for multiple tests across different
modalities. MosaiQ is designed to be a game-changing solution,
which Quotient believes will increase efficiencies, improve
clinical practice, deliver significant workflow improvements, and
create operational cost savings to laboratories around the world.
Quotient's operations are based in Eysins, Switzerland, Edinburgh,
Scotland and Newtown, Pennsylvania.
CONTACT: Peter Buhler, Chief
Financial Officer – IR@quotientbd.com; +41 22 545 52 26
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Sep 2023 to Sep 2024